| Literature DB >> 36071816 |
Hao Gao1, Hao Yin1, Li Peng1, Han Wang2.
Abstract
Background: With the widespread promotion of the COVID-19 vaccination in China, videos about the vaccination have become increasingly available on social video platforms. With the User Generated Content model, different creators' interpretations of COVID-19 vaccines may influence the attitudes towards the vaccines and vaccination. Objective: To explore the overview of COVID-19 vaccine-related videos on Bilibili, discussing the communication effects of COVID-19 topic videos and its influencing factors.Entities:
Keywords: Bilibili; COVID-19 vaccine; health promotion; social media; vaccination
Year: 2022 PMID: 36071816 PMCID: PMC9444025 DOI: 10.2147/RMHP.S374420
Source DB: PubMed Journal: Risk Manag Healthc Policy ISSN: 1179-1594
Dependent Variable and Independent Variables
| Types | Factor | Category | Description |
|---|---|---|---|
| Creator information | Type of creators | 1=Individuals | According to the creators’ homepage certification and profile information. |
| 2=Medical workers | |||
| 3=Media | |||
| 4=Corporate companies | |||
| Number of followers | Number of followers displayed on the homepage | ||
| Video presentation | Video type | 1=Vlog | Typical YouTube-style; the author mainly records in the form of the camera |
| 2=Showcase | The author’s voice appears as a voice-over to comment and narrate the videos, pictures, data, and other materials appearing on the screen. | ||
| 3=Animation | Live paintings and various types of video animations. | ||
| 4=Interview | Videos with interviews, conversations, chats, and online interviews conducted by the host and interviewees. | ||
| 5=Short films | Short documentaries, microfilms, and other short films. | ||
| 6=News | News-style short films or TV news clips. | ||
| Cover | 0=No | Whether the video has a cover related to the video content, | |
| 1=Yes | |||
| Visual effects | 1=No | The presence of animation, mirroring, special effects, and other effects in the video can enhance video viewing. | |
| 2=Yes | |||
| Video duration | 1= Less than 10min | According to the creators’ homepage certification and profile information. | |
| 2= 10min–30min | |||
| 3= >30min and ≤ 60min | |||
| 4= Greater than 60min | |||
| COVID-19-related content features | Scientific basis | 0=No | The content-related ted to the COVID-19 vaccine cites scientific basis, such as professional literature, books, and websites. It is shown in the video in the form of text and pictures, which the audience can retrieve. |
| 1=Yes | |||
| Core topic | 0=No | Have a core topic related to the COVID-19 vaccine and be discussed in the video. | |
| 1=Yes | |||
| Cues to action | 0=No | The communicator advocated in the video to encourage the audience to vaccinate. | |
| 1=Yes | |||
| Vaccine attitude | 1=Negative | Communicator’s attitudes towards COVID-19 vaccination behavior in the video. | |
| 2=Neutral | |||
| 3=Positive | |||
| Knowledge points of COVID-19 vaccine | 1. The type of vaccine | One point for each element covered in the video, for 7 points. | |
| 2. The mechanism of action of the vaccine | |||
| 3. Animal or human trials | |||
| 4. The efficacy of the COVID-19 vaccine | |||
| 5. The safety of the COVID-19 vaccine | |||
| 6. The manufacturing process of the vaccine | |||
| 7. Herd immunity (Immune barrier) | |||
| Issues related to COVID-19 vaccination | 1. Contraindicated groups | One point for each element covered in the video, for 6 points. | |
| 2. Suitable groups | |||
| 3. Adverse reactions after vaccination | |||
| 4. Feelings about vaccination | |||
| 5. The brand of vaccination | |||
| 6. Procedures for vaccination | |||
| Communication effect | Communication breadth (Logarithmic value) | Number of retweets | According to the video information on the website. |
| Communication recognition (Logarithmic value of sum) | 1. Number of plays | ||
| 2. Number of likes | |||
| 3. Number of favorites | |||
| 4. Number of coins | |||
| Communication participation (Logarithmic value of sum) | 1. Number of bullet subtitles | ||
| 2. Number of comments |
Figure 1Overall overview of the COVID-19 vaccine topic videos.
Chi-Square Analysis Results Between Creator Type and Video Type
| Title | Name | Creator Type (%) | Total | p | ||||
|---|---|---|---|---|---|---|---|---|
| Individuals | Medical Workers | Media | Corporate Companies | |||||
| Video types | Vlog | 41(54.67) | 29(96.67) | 9(9.78) | 0(0.00) | 79(39.11) | 116.915 | 0.000** |
| Showcase | 18(24.00) | 1(3.33) | 24(26.09) | 2(40.00) | 45(22.28) | |||
| Animation | 8(10.67) | 0(0.00) | 1(1.09) | 1(20.00) | 10(4.95) | |||
| Interview | 3(4.00) | 0(0.00) | 15(16.30) | 1(20.00) | 19(9.41) | |||
| Short film | 1(1.33) | 0(0.00) | 3(3.26) | 0(0.00) | 4(1.98) | |||
| News | 4(5.33) | 0(0.00) | 40(43.48) | 1(20.00) | 45(22.28) | |||
| Total | 75 | 30 | 92 | 5 | 202 | |||
Note: **p<0.01.
Chi-Square Analysis Between Creator Types and Issues Related to COVID-19 Vaccination
| Title | Name | Creator Type (%) | Total | p | ||||
|---|---|---|---|---|---|---|---|---|
| Individuals | Medical Workers | Media | Corporate Companies | |||||
| Issue 1 | None | 68(90.67) | 26(86.67) | 82(89.13) | 5(100.00) | 181(89.60) | 0.971 | 0.808 |
| Yes | 7(9.33) | 4(13.33) | 10(10.87) | 0(0.00) | 21(10.40) | |||
| Total | 75 | 30 | 92 | 5 | 202 | |||
| Issue 2 | None | 63(84.00) | 18(60.00) | 68(73.91) | 4(80.00) | 153(75.74) | 7.047 | 0.07 |
| Yes | 12(16.00) | 12(40.00) | 24(26.09) | 1(20.00) | 49(24.26) | |||
| Total | 75 | 30 | 92 | 5 | 202 | |||
| Issue 3 | None | 38(50.67) | 22(73.33) | 63(68.48) | 4(80.00) | 127(62.87) | 8.06 | 0.045* |
| Yes | 37(49.33) | 8(26.67) | 29(31.52) | 1(20.00) | 75(37.13) | |||
| Total | 75 | 30 | 92 | 5 | 202 | |||
| Issue 4 | None | 60(80.00) | 29(96.67) | 79(85.87) | 5(100.00) | 173(85.64) | 5.75 | 0.124 |
| Yes | 15(20.00) | 1(3.33) | 13(14.13) | 0(0.00) | 29(14.36) | |||
| Total | 75 | 30 | 92 | 5 | 202 | |||
| Issue 5 | None | 42(56.00) | 19(63.33) | 42(45.65) | 3(60.00) | 106(52.48) | 3.623 | 0.305 |
| Yes | 33(44.00) | 11(36.67) | 50(54.35) | 2(40.00) | 96(47.52) | |||
| Total | 75 | 30 | 92 | 5 | 202 | |||
| Issue 6 | None | 52(69.33) | 18(60.00) | 77(83.70) | 5(100.00) | 152(75.25) | 10.323 | 0.016* |
| Yes | 23(30.67) | 12(40.00) | 15(16.30) | 0(0.00) | 50(24.75) | |||
| Total | 75 | 30 | 92 | 5 | 202 | |||
Notes: Issue 1: contraindicated groups for COVID-19 vaccination; Issue 2: suitable groups for COVID-19 vaccination; Issue 3: adverse reactions after COVID-19 vaccination; Issue 4: the Feeling of Vaccination; Issue 5: brands of COVID-19 vaccine; Issue 6: procedures for COVID-19 vaccination. *p<0.05.
Analysis of ANOVA Results
| Creator Type (M ± SD) | F | p | ||||
|---|---|---|---|---|---|---|
| Individuals (n=75) | Medical Workers (n=30) | Media (n=92) | Corporate Companies (n=5) | |||
| The richness of Vaccine knowledge | 2.19±1.70 | 2.03±1.40 | 1.85±1.58 | 2.60±1.14 | 0.855 | 0.465 |
| The richness of Vaccine issues | 1.69±1.28 | 1.60±1.28 | 1.53±1.10 | 0.80±0.84 | 0.985 | 0.401 |
| Vaccine attitude | 3.83±1.28 | 4.20±1.00 | 3.93±1.31 | 4.20±1.10 | 0.709 | 0.547 |
| Communication breadth | 1.89±1.07 | 2.28±0.97 | 2.49±0.80 | 1.99±0.89 | 5.913 | 0.001** |
| Communication recognition | 3.98±1.01 | 3.84±0.96 | 4.45±0.60 | 3.63±1.09 | 7.012 | 0.000** |
| Communication participation | 2.07±0.94 | 2.01±0.89 | 2.47±0.59 | 1.44±1.22 | 6.274 | 0.000** |
Note: **p<0.01.
Bivariate Correlation Analysis Between Video Spread and Other Variables
| Breadth of Dissemination | Creator Type | Cover (With) | Video Type | Video Duration | Professional Basis (With) | Number of Followers | Core Issues (With) | The Richness of Vaccine Issues | The Richness of Vaccine Knowledge Points | Cues to Action (With) | Vaccine Attitude | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Creator type | 0.256** | 1 | ||||||||||
| Cover (with) | 0.125 | −0.159* | 1 | |||||||||
| Video type | 0.116 | 0.502** | −0.296** | 1 | ||||||||
| Video duration | −0.03 | −0.118 | 0.022 | −0.141* | 1 | |||||||
| Professional basis (with) | 0.072 | −0.116 | 0.096 | −0.224** | 0.296** | 1 | ||||||
| Number of followers | 0.359** | 0.364** | −0.089 | 0.380** | −0.012 | 0.017 | 1 | |||||
| Core issues (with) | 0.270** | −0.112 | 0.297** | −0.204** | 0.06 | 0.242** | 0.065 | 1 | ||||
| The richness of Vaccine issues | −0.107 | −0.091 | 0.1 | −0.088 | 0.042 | −0.095 | 0.03 | 0.006 | 1 | |||
| The richness of Vaccine knowledge points | 0.04 | −0.074 | 0.124 | −0.019 | 0.193** | 0.169* | 0.089 | 0.413** | −0.061 | 1 | ||
| Cues to action(with) | −0.049 | 0.011 | 0.017 | 0.002 | −0.102 | −0.005 | −0.02 | 0.117 | 0.041 | 0.023 | 1 | |
| Vaccine attitude | 0.077 | 0.044 | 0.143* | 0.049 | −0.092 | 0.007 | 0.108 | 0.084 | −0.023 | 0.021 | 0.367** | 1 |
Note: *p<0.05 **p<0.01.
Bivariate Correlation Analysis Between Video Communication Approval and Other Variables
| Communication Identity | Creator Type | Cover (With) | Video Type | Video Duration | Professional Basis (With) | Number of Followers | Core | The Richness of Vaccine Issues | The Richness of Vaccine Knowledge Points | Cues to Action (With) | Vaccine Attitude | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Creator type | 0.208** | 1 | ||||||||||
| Cover (with) | 0.151* | −0.159* | 1 | |||||||||
| Video type | 0.158* | 0.502** | −0.296** | 1 | ||||||||
| Video duration | −0.115 | −0.118 | 0.022 | −0.141* | 1 | |||||||
| Professional basis (with) | −0.029 | −0.116 | 0.096 | −0.224** | 0.296** | 1 | ||||||
| Number of followers | 0.364** | 0.364** | −0.089 | 0.380** | −0.012 | 0.017 | 1 | |||||
| Core issues (with) | −0.028 | −0.112 | 0.297** | −0.204** | 0.06 | 0.242** | 0.065 | 1 | ||||
| The richness of Vaccine issues | −0.047 | −0.091 | 0.1 | −0.088 | 0.042 | −0.095 | 0.03 | 0.006 | 1 | |||
| The richness of Vaccine knowledge points | −0.190** | −0.074 | 0.124 | −0.019 | 0.193** | 0.169* | 0.089 | 0.413** | −0.061 | 1 | ||
| Cues to action (with) | −0.064 | 0.011 | 0.017 | 0.002 | −0.102 | −0.005 | −0.02 | 0.117 | 0.041 | 0.023 | 1 | |
| Vaccine attitude | 0.219** | 0.044 | 0.143* | 0.049 | −0.092 | 0.007 | 0.108 | 0.084 | −0.023 | 0.021 | 0.367** | 1 |
Note: *p<0.05 **p<0.01.
Bivariate Correlation Analysis Between Video Communication Engagement and Other Variables
| Communication Engagement | Creator Type | Cover (With) | Video Type | Video Duration | Professional Basis (With) | Number of Followers | Core Issues (With) | The Richness of Vaccine Issues | The Richness of Vaccine Knowledge Points | Cues to Action (With) | Vaccine Attitude | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Creator type | 0.168* | 1 | ||||||||||
| Cover (with) | 0.217** | −0.159* | 1 | |||||||||
| Video type | 0.095 | 0.502** | −0.296** | 1 | ||||||||
| Video duration | −0.092 | −0.118 | 0.022 | −0.141* | 1 | |||||||
| Professional basis (with) | 0.054 | −0.116 | 0.096 | −0.224** | 0.296** | 1 | ||||||
| Number of followers | 0.397** | 0.364** | −0.089 | 0.380** | −0.012 | 0.017 | 1 | |||||
| Core issues (with) | 0.047 | −0.112 | 0.297** | −0.204** | 0.06 | 0.242** | 0.065 | 1 | ||||
| The richness of Vaccine issues | 0.03 | −0.091 | 0.1 | −0.088 | 0.042 | −0.095 | 0.03 | 0.006 | 1 | |||
| The richness of Vaccine knowledge points | −0.167* | −0.074 | 0.124 | −0.019 | 0.193** | 0.169* | 0.089 | 0.413** | −0.061 | 1 | ||
| Cues to action (with) | −0.015 | 0.011 | 0.017 | 0.002 | −0.102 | −0.005 | −0.02 | 0.117 | 0.041 | 0.023 | 1 | |
| Vaccine attitude | 0.223** | 0.044 | 0.143* | 0.049 | −0.092 | 0.007 | 0.108 | 0.084 | −0.023 | 0.021 | 0.367** | 1 |
Note: *p<0.05 **p<0.01.
Results of Stratified Regression Analysis with the Dependent Variable Being Communication Participation
| Model 1 | Model 2 | |||
|---|---|---|---|---|
| B | SE | B | SE | |
| Constant | 1.585** | 0.224 | 0.011 | 0.304 |
| Creator type | 0.144* | 0.068 | −0.048 | 0.058 |
| Cover (with) | 0.464** | 0.129 | 0.231* | 0.108 |
| Animation special effects (with) | 0.167 | 0.128 | 0.119 | 0.12 |
| Video type | 0.032 | 0.034 | 0.005 | 0.03 |
| Video duration | −0.104 | 0.096 | −0.078 | 0.081 |
| Professional basis (with) | 0.149 | 0.143 | ||
| Number of followers | 0.372** | 0.038 | ||
| Expression of interest | 0.032 | 0.046 | ||
| The degree of storytelling | 0.033 | 0.04 | ||
| Core issues (with) | 0.043 | 0.113 | ||
| The richness of vaccine issues | 0 | 0.047 | ||
| The richness of vaccine knowledge points | −0.115* | 0.049 | ||
| Cues to action (with) | −0.051 | 0.115 | ||
| Vaccine attitude | 0.069 | 0.04 | ||
| R2 | 0.108 | 0.474 | ||
| Adjusted R2 | 0.085 | 0.434 | ||
| F | F (5196)=4.723, p=0.000 | F (14,187)=12.023, p=0.000 | ||
| ΔR2 | 0.108 | 0.366 | ||
| ΔF | F (5196)=4.723, p=0.000 | F (9187)=14.457, p=0.000 | ||
| Dependent variable | Communication participation | |||
Note: *p<0.05 **p<0.01.
Results of the Stratified Regression Analysis with the Dependent Variable Being Communication Breadth
| Model 1 | Model 2 | |||
|---|---|---|---|---|
| B | SE | B | SE | |
| Constant | 1.292** | 0.26 | 0.268 | 0.388 |
| Creator type | 0.282** | 0.078 | 0.094 | 0.075 |
| Cover (with) | 0.322* | 0.149 | 0.036 | 0.137 |
| Animation special effects (with) | 0.386** | 0.148 | 0.22 | 0.154 |
| Video type | 0.008 | 0.039 | −0.013 | 0.038 |
| Video duration | −0.018 | 0.111 | −0.006 | 0.103 |
| Professional basis (with) | 0.003 | 0.182 | ||
| Number of followers | 0.342** | 0.049 | ||
| Expression of interest | 0.023 | 0.058 | ||
| The degree of storytelling | −0.007 | 0.051 | ||
| Core issues (with) | 0.499** | 0.145 | ||
| The richness of vaccine issues | −0.122* | 0.061 | ||
| The richness of vaccine knowledge points | −0.047 | 0.063 | ||
| Cues to action (with) | −0.095 | 0.147 | ||
| Vaccine attitude | −0.021 | 0.051 | ||
| R2 | 0.125 | 0.37 | ||
| Adjusted R2 | 0.102 | 0.323 | ||
| F | F (5196)=5.589, p=0.000 | F (14,187)=7.853, p=0.000 | ||
| ΔR2 | 0.125 | 0.245 | ||
| ΔF | F (5196)=5.589, p=0.000 | F (9187)=8.098, p=0.000 | ||
| Dependent variable | Communication breadth | |||
Note: *p<0.05 **p<0.01.
Results of Stratified Regression Analysis with the Dependent Variable Being Communication Recognition
| Model 1 | Model 2 | |||
|---|---|---|---|---|
| B | SE | B | SE | |
| Constant | 3.504** | 0.238 | 1.919** | 0.328 |
| Creator type | 0.164* | 0.072 | −0.021 | 0.063 |
| Cover (with) | 0.384** | 0.136 | 0.187 | 0.116 |
| Animation special effects (with) | 0.239 | 0.135 | 0.207 | 0.13 |
| Video type | 0.05 | 0.036 | 0.021 | 0.032 |
| Video duration | −0.136 | 0.101 | −0.083 | 0.087 |
| Professional basis (with) | −0.041 | 0.154 | ||
| Number of followers | 0.364** | 0.041 | ||
| Expression of interest | 0.032 | 0.049 | ||
| The degree of storytelling | 0.066 | 0.043 | ||
| Core issues (with) | −0.011 | 0.122 | ||
| The richness of vaccine issues | −0.067 | 0.051 | ||
| The richness of vaccine knowledge points | −0.125* | 0.053 | ||
| Cues to action (with) | −0.151 | 0.124 | ||
| Vaccine attitude | 0.092* | 0.043 | ||
| R2 | 0.112 | 0.457 | ||
| Adjusted R2 | 0.089 | 0.417 | ||
| F | F (5196)=4.927, p=0.000 | F (14,187)=11.252, p=0.000 | ||
| ΔR2 | 0.112 | 0.346 | ||
| ΔF | F (5196)=4.927, p=0.000 | F (9187)=13.229, p=0.000 | ||
| Dependent variable | Communication recognition | |||
Note: *p<0.05 **p<0.01.